New combined method for Ng insertion in Unconscious Intubated Patients

Comparison of the efficiency of The Combined Method of Nasogastric Tube Insertion with The Conventional Method in Unconscious Intubated Patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230623058561N1

Enrollment

Registered

2023-11-07

Start date

2023-11-11

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NG tube insertion in intubated and unconsciousness patients.

Interventions

Intervention 1: 1. In the combined method, first, the tube that is kept at 4 degrees is filled with cold normal saline (4 degrees) with the help of a gavage syringe, and the tube is clamped to prevent

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Order of physician for Ng tube insertion age more than 18 patients must be intubated patient must be unconsciousness and not cooperating ( GCS<9 or Ras < -2 or ACVPU = U ) Dose not have current bleeding Dose not have any fractures in base skull Dose not have esophageal varices Not having recent surgeries in esophageal area

Exclusion criteria

Exclusion criteria: Unstable hemodynamics when patient need resuscitation Narrowing or deviation of nostrils ( The NG tube dose not go forward in esophagus by nostrils ) Bradycardia ( HR <60)

Design outcomes

Primary

Measure	Time frame
Comparison of the number of success in NG tube placement in the combined method with the conventional method. Timepoint: Immediately after NG insertion. Method of measurement: Checking the correct placement by Injecting 20cc of Bolus air into Tube and checking the bulb sound in stomach by stethoscope.;Comparing the number of attempts to insert the tube in the combined method with the conventional method. Timepoint: Immediately after NG insertion. Method of measurement: Correct NG tube Placement on the first or second attempt is considered a success. Each attempt is equivalent to a duration of less than 90 seconds.;Comparison of the elapsed time for tube placement in the combined method with the conventional method. Timepoint: Immediately after NG insertion. Method of measurement: Placement time measurement with chronometer.;Comparison of immediate complications caused by tube placement in the combined method with the conventional method. Timepoint: Immediately after NG insertion. Method of measurement: Immediate complications include bleeding due to traumatization, twisting of the tube, bradycardia during tube placement, entering the nasogastric tube into the trachea, which is measured after tube placement.	—

Measure

Time frame

Comparison of the number of success in NG tube placement in the combined method with the conventional method. Timepoint: Immediately after NG insertion. Method of measurement: Checking the correct placement by Injecting 20cc of Bolus air into Tube and checking the bulb sound in stomach by stethoscope.;Comparing the number of attempts to insert the tube in the combined method with the conventional method. Timepoint: Immediately after NG insertion. Method of measurement: Correct NG tube Placement on the first or second attempt is considered a success. Each attempt is equivalent to a duration of less than 90 seconds.;Comparison of the elapsed time for tube placement in the combined method with the conventional method. Timepoint: Immediately after NG insertion. Method of measurement: Placement time measurement with chronometer.;Comparison of immediate complications caused by tube placement in the combined method with the conventional method. Timepoint: Immediately after NG insertion. Method of measurement: Immediate complications include bleeding due to traumatization, twisting of the tube, bradycardia during tube placement, entering the nasogastric tube into the trachea, which is measured after tube placement.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Razghandi

Mashhad University of Medical Sciences

razghandis3@mums.ac.ir+98 51 4466 7647

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026